PETER ILLEI

Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology BALTIMORE, MD NPI 1720071459

General Payments — all program years on this page

$170,829.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 143
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $13,492.85 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $11,939.254
Travel and Lodging $1,194.995
Food and Beverage $358.615

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $8,832.436
Acerta Pharma LLC $3,601.752
Boehringer Ingelheim Pharmaceuticals, Inc. $795.063
Daiichi Sankyo Inc. $188.102
Merck Sharp & Dohme Corporation $75.511

By program year

Program yearAmountRecords
2018 $23,447.2611
2019 $21,297.9324
2020 $28,042.8915
2021 $13,367.199
2022 $49,594.7148
2023 $21,586.4922
2024 $13,492.8514

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089436142 Daiichi Sankyo Inc. $102.52 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089436144 Daiichi Sankyo Inc. $85.58 09/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103135501 ABBVIE INC. $4,350.00 09/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103135503 ABBVIE INC. $3,987.50 10/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103965197 ABBVIE INC. $70.00 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103965199 ABBVIE INC. $25.00 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104189638 ABBVIE INC. $381.03 06/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1104189640 ABBVIE INC. $18.90 09/24/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1104425569 AstraZeneca Pharmaceuticals LP $365.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104746799 AstraZeneca Pharmaceuticals LP $3,236.75 10/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118126683 Boehringer Ingelheim Pharmaceuticals, Inc. $174.30 12/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118126685 Boehringer Ingelheim Pharmaceuticals, Inc. $174.30 12/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118126687 Boehringer Ingelheim Pharmaceuticals, Inc. $446.46 11/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141674969 Merck Sharp & Dohme LLC $75.51 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.